MedPath

Efficacy of nuclear medicine imaging to detect fibroblast activation protein in pancreatic and biliary tract cancer.

Not Applicable
Active, not recruiting
Conditions
Neoplasms
Registration Number
KCT0009207
Lead Sponsor
Seoul National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Adults over 20 years old
- Patients suspected of having pancreatic cancer or biliary tract cancer on imaging tests including CT and PET/CT and confirmed to have cancer on biopsy
- Patients in whom cancer was not confirmed on biopsy due to difficulty in histological examination before surgery, but surgical treatment was planned due to strong suspicion of cancer based on clinical picture and imaging examination
- Patients who can provide written consent and comply with the research requirements before starting to participate in the study.
- Patients who gave written consent to establish a Bio Repository for liver, biliary tract, and pancreatic tumor research (H-0901-010-267)

Exclusion Criteria

- Patients who are pregnant or lactating
- Patients with a history of clinically significant uncontrolled seizures, central nervous system disease, or mental illness that, in the opinion of the investigator, may interfere with or interfere with the subject's ability to understand the consent form.
- Subjects who develop uncontrolled severe infection or other uncontrolled serious comorbidities
- Patients who have undergone other major surgery within 4 weeks prior to the study or who have not fully recovered from the effects of major surgery.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in measured variables related to expression of cancer associated fibroblasts according to clinical characteristics and tumor stage (T-stage, N-stage)
Secondary Outcome Measures
NameTimeMethod
Verification of correlation between variables measured in CT, FDG PET, FAPI PET and quantitative indices of RNA and Protein obtained from postoperative tissues
© Copyright 2025. All Rights Reserved by MedPath